These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 340039)

  • 21. Phase II trial of piperazinedione in malignant melanoma: a report by the Southeastern Cancer Study Group.
    Presant CA; Bartolucci AA; Ungaro P; Oldham R
    Cancer Treat Rep; 1979 Aug; 63(8):1367-9. PubMed ID: 476710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA; Markus S; Aisner J; Wiernik PH
    Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
    Garim AM; Lorie IuI; Reĭzinger MA; Shkarenkov VA; Durnov LA
    Antibiotiki; 1967 Jul; 12(7):609-19. PubMed ID: 4299328
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of determining the sensitivity of hypernephroid cancer to cytostatic agents in vitro and clinically].
    Terent'eva TG; Matveev BP; Martochkina GA; Marinbakh EB
    Antibiotiki; 1977 Jul; 22(7):648-52. PubMed ID: 329755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced non-small cell lung cancer with bisantrene.
    Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
    Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
    Kvols LK; Eagan RT; Myers RP
    Cancer Treat Rep; 1977; 61(2):311-2. PubMed ID: 326400
    [No Abstract]   [Full Text] [Related]  

  • 27. [Administration of antineoplastic agent of high molecular weight, neocarzinostatin, in cases of gastric cancer].
    Aneha Y; Kikuchi K; Kanno H
    Nihon Rinsho; 1974 Apr; 32(4):870-4. PubMed ID: 4858854
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.
    Gralla RJ; Sordillo PP; Magill GB
    Cancer Treat Rep; 1978 Oct; 62(10):1573-4. PubMed ID: 361228
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of advanced adenocarcinoma of the kidney with ICRF-187: a Southeastern Cancer Study Group Trial.
    Brubaker LH; Vogel CL; Einhorn LH; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):915-6. PubMed ID: 3087618
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the medical treatment of metastases of hypernephroid cancer of the kidneys].
    Evseenko LS; Orlova RS; Barsel' VA; Disvetova VV
    Vopr Onkol; 1966; 12(9):53-5. PubMed ID: 6004069
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy with hydroxyurea (NSC-32065) in renal cell carcinoma.
    Nevinny HB; Hall TC
    J Clin Pharmacol J New Drugs; 1968; 8(6):352-9. PubMed ID: 4883783
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of VM-26 as a single agent in the treatment of renal carcinoma.
    Hire EA; Samson MK; Fraile RJ; Baker LH
    Cancer Clin Trials; 1979; 2(4):293-5. PubMed ID: 394865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of pyrazofurin in advanced colorectal carcinoma.
    Creagan ET; Rubin J; Moertel CG; Schutt AJ; O'connell MJ; Hahn RG; Reitemeir RJ; Frytak S
    Cancer Treat Rep; 1977; 61(3):491-3. PubMed ID: 872147
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
    Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
    Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 38. [A phase II study of SM-5887 for advanced gastric cancer].
    Tsushima K; Sakata Y; Munakata A; Sato T; Chiba Y; Nara H; Kawazu S; Matsukawa M; Ohmi T; Aizawa T
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1151-4. PubMed ID: 1647150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of chlorozotocin in patients with renal cell carcinoma.
    Gralla RJ; Yagoda A
    Cancer Treat Rep; 1979 Jun; 63(6):1007-8. PubMed ID: 157222
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
    Luderer RC; Opipari MI; Perrotta AL
    J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.